SCHEMBL7225388

SCHEMBL7225388

C#CCCCO.[LiH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8687 0.97
SCHEMBL40550 0.87
SCHEMBL18975256 0.84 HSD17B10 (0.50)
SCHEMBL130493 0.84 HSD17B10 (0.50)
SCHEMBL2335615 0.84 HSD17B10 (0.50)
SCHEMBL23014949 0.84 HSD17B10 (0.50)
SCHEMBL8907249 0.84 HSD17B10 (0.50)
SCHEMBL130671 0.84
SCHEMBL23014965 0.84 HSD17B10 (0.50)
Hydrochloric Acid SCHEMBL5806207 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562963-B2 Coupling using organosilicon compound BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-05-13 US disclosed
US-20020013459-A1 Process for the preparation of macrocyclic metalloprotease inhibitors BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-01-31 US disclosed
US-6307044-B1 Process for the preparation of macrocyclic metalloprotease inhibitors DUPONT PHARMACEUTICALS COMPANY 2001-10-23 US disclosed
EP-1084113-A1 A PROCESS FOR THE PREPARATION OF MACROCYCLIC METALLOPROTEASE INHIBITORS Du Pont Pharmaceuticals Company (US) 2001-03-21 EP disclosed
WO-1999064406-A1 A PROCESS FOR THE PREPARATION OF MACROCYCLIC METALLOPROTEASE INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1999-12-16 WO disclosed